123 related articles for article (PubMed ID: 7798613)
1. Topical retinaldehyde on human skin: biologic effects and tolerance.
Saurat JH; Didierjean L; Masgrau E; Piletta PA; Jaconi S; Chatellard-Gruaz D; Gumowski D; Masouyé I; Salomon D; Siegenthaler G
J Invest Dermatol; 1994 Dec; 103(6):770-4. PubMed ID: 7798613
[TBL] [Abstract][Full Text] [Related]
2. Topical retinaldehyde increases skin content of retinoic acid and exerts biologic activity in mouse skin.
Didierjean L; Carraux P; Grand D; Sass JO; Nau H; Saurat JH
J Invest Dermatol; 1996 Nov; 107(5):714-9. PubMed ID: 8875955
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of topical retinaldehyde.
Didierjean L; Tran C; Sorg O; Saurat JH
Dermatology; 1999; 199 Suppl 1():19-24. PubMed ID: 10473955
[TBL] [Abstract][Full Text] [Related]
4. Tolerance of topical retinaldehyde in humans.
Sachsenberg-Studer EM
Dermatology; 1999; 199 Suppl 1():61-3. PubMed ID: 10473964
[TBL] [Abstract][Full Text] [Related]
5. Topical 9-cis-retinaldehyde for delivery of 9-cis-retinoic acid in mouse skin.
Didierjean L; Sass JO; Carraux P; Grand D; Sorg O; Plum C; Nau H; Saurat JH
Exp Dermatol; 1999 Jun; 8(3):199-203. PubMed ID: 10389637
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of topical retinaldehyde.
Sorg O; Didierjean L; Saurat JH
Dermatology; 1999; 199 Suppl 1():13-7. PubMed ID: 10473954
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical 0.05% retinaldehyde in skin aging by ultrasound and rheological techniques.
Diridollou S; Vienne MP; Alibert M; Aquilina C; Briant A; Dahan S; Denis P; Launais B; Turlier V; Dupuy P
Dermatology; 1999; 199 Suppl 1():37-41. PubMed ID: 10473959
[TBL] [Abstract][Full Text] [Related]
8. Plasma retinoids after topical use of retinaldehyde on human skin.
Sass JO; Masgrau E; Piletta PA; Nau H; Saurat JH
Skin Pharmacol; 1996; 9(5):322-6. PubMed ID: 8990507
[TBL] [Abstract][Full Text] [Related]
9. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14.
Rosenthal DS; Griffiths CE; Yuspa SH; Roop DR; Voorhees JJ
J Invest Dermatol; 1992 Mar; 98(3):343-50. PubMed ID: 1372028
[TBL] [Abstract][Full Text] [Related]
10. Retinoid induction of CRABP II mRNA in human dermal fibroblasts: use as a retinoid bioassay.
Elder JT; Kaplan A; Cromie MA; Kang S; Voorhees JJ
J Invest Dermatol; 1996 Mar; 106(3):517-21. PubMed ID: 8648186
[TBL] [Abstract][Full Text] [Related]
11. Unoccluded retinol penetrates human skin in vivo more effectively than unoccluded retinyl palmitate or retinoic acid.
Duell EA; Kang S; Voorhees JJ
J Invest Dermatol; 1997 Sep; 109(3):301-5. PubMed ID: 9284094
[TBL] [Abstract][Full Text] [Related]
12. Comedolytic effect of topical retinaldehyde in the rhino mouse model.
Fort-Lacoste L; Verscheure Y; Tisne-Versailles J; Navarro R
Dermatology; 1999; 199 Suppl 1():33-5. PubMed ID: 10473958
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of topical retinaldehyde on photoaged skin.
Creidi P; Humbert P
Dermatology; 1999; 199 Suppl 1():49-52. PubMed ID: 10473961
[TBL] [Abstract][Full Text] [Related]
14. Control of epidermal differentiation by a retinoid analogue unable to bind to cytosolic retinoic acid-binding proteins (CRABP).
Asselineau D; Cavey MT; Shroot B; Darmon M
J Invest Dermatol; 1992 Feb; 98(2):128-34. PubMed ID: 1370673
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression.
Griffiths CE; Elder JT; Bernard BA; Rossio P; Cromie MA; Finkel LJ; Shroot B; Voorhees JJ
J Invest Dermatol; 1993 Sep; 101(3):325-8. PubMed ID: 8396608
[TBL] [Abstract][Full Text] [Related]
16. Short-term retinoic acid treatment increases in vivo, but decreases in vitro, epidermal transglutaminase-K enzyme activity and immunoreactivity.
Griffiths CE; Rosenthal DS; Reddy AP; Elder JT; Astrom A; Leach K; Wang TS; Finkel LJ; Yuspa SH; Voorhees JJ
J Invest Dermatol; 1992 Sep; 99(3):283-8. PubMed ID: 1355099
[TBL] [Abstract][Full Text] [Related]
17. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation.
Kang S; Duell EA; Fisher GJ; Datta SC; Wang ZQ; Reddy AP; Tavakkol A; Yi JY; Griffiths CE; Elder JT
J Invest Dermatol; 1995 Oct; 105(4):549-56. PubMed ID: 7561157
[TBL] [Abstract][Full Text] [Related]
18. Cellular localization of mRNA for cellular retinoic acid-binding protein II and nuclear retinoic acid receptor-gamma 1 in retinoic acid-treated human skin.
Tavakkol A; Griffiths CE; Keane KM; Palmer RD; Voorhees JJ
J Invest Dermatol; 1992 Aug; 99(2):146-50. PubMed ID: 1378478
[TBL] [Abstract][Full Text] [Related]
19. Response of psoriasis to a new topical retinoid, AGN 190168.
Esgleyes-Ribot T; Chandraratna RA; Lew-Kaya DA; Sefton J; Duvic M
J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583
[TBL] [Abstract][Full Text] [Related]
20. Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions.
Fluhr JW; Vienne MP; Lauze C; Dupuy P; Gehring W; Gloor M
Dermatology; 1999; 199 Suppl 1():57-60. PubMed ID: 10473963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
